Voriconazole use for endemic fungal infections

Alison Freifeld; Laurie Proia; David Andes; Larry M. Baddour; Janis Blair; Brad Spellberg; Sandra Arnold; Arnold Lentnek; L. Joseph Wheat

doi:10.1128/AAC.01148-07

Voriconazole use for endemic fungal infections

Alison Freifeld, Laurie Proia, David Andes, Larry M. Baddour, Janis Blair, Brad Spellberg, Sandra Arnold, Arnold Lentnek, L. Joseph Wheat

Infectious Diseases

Research output: Contribution to journal › Article › peer-review

94 Scopus citations

Abstract

In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.

Original language	English (US)
Pages (from-to)	1648-1651
Number of pages	4
Journal	Antimicrobial Agents and Chemotherapy
Volume	53
Issue number	4
DOIs	https://doi.org/10.1128/AAC.01148-07
State	Published - Apr 2009

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Access to Document

10.1128/AAC.01148-07

Cite this

@article{4ac1e20c09e44c40ba8783404b138597,

title = "Voriconazole use for endemic fungal infections",

abstract = "In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.",

author = "Alison Freifeld and Laurie Proia and David Andes and Baddour, {Larry M.} and Janis Blair and Brad Spellberg and Sandra Arnold and Arnold Lentnek and Wheat, {L. Joseph}",

year = "2009",

month = apr,

doi = "10.1128/AAC.01148-07",

language = "English (US)",

volume = "53",

pages = "1648--1651",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "4",

}

TY - JOUR

T1 - Voriconazole use for endemic fungal infections

AU - Freifeld, Alison

AU - Proia, Laurie

AU - Andes, David

AU - Baddour, Larry M.

AU - Blair, Janis

AU - Spellberg, Brad

AU - Arnold, Sandra

AU - Lentnek, Arnold

AU - Wheat, L. Joseph

PY - 2009/4

Y1 - 2009/4

N2 - In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.

AB - In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.

UR - http://www.scopus.com/inward/record.url?scp=65649147960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649147960&partnerID=8YFLogxK

U2 - 10.1128/AAC.01148-07

DO - 10.1128/AAC.01148-07

M3 - Article

C2 - 19139290

AN - SCOPUS:65649147960

SN - 0066-4804

VL - 53

SP - 1648

EP - 1651

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 4

ER -

Voriconazole use for endemic fungal infections

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this